Pain R&D Firms Target Nerve Cell Signaling In Hunt For Potent Non-Opioids

Analgesic drug development is one of the most active areas of early-stage R&D, led by a new generation of ion channel modulators that target nerve cell transmission without affecting other body systems. Cone snail venom derivatives like Elan's Prialt stand out as potent ion channel blockers.